Nifty
:
23547.75
Sensex
:
74775.74
-359.40 (-1.50%)
-1092.06 (-1.44%)
Nifty
Sensex
:
:
23547.75
74775.74
-359.40 (-1.50%)
-1092.06 (-1.44%)

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

Rating :
64/99

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
8176.50
29-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  8176.5
  •  8325
  •  8146
  •  8272.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1042419
  •  8550662488.5
  •  8443
  •  6696.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,17,586.37
  • 60.56
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,22,128.07
  • 0.24%
  • 12.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 28.02%
  • 0.61%
  • 4.40%
  • FII
  • DII
  • Others
  • 42.62%
  • 21.54%
  • 2.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.37
  • 15.59
  • 9.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 21.67
  • 8.07

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.85
  • 57.41
  • 18.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 85.49
  • 77.84
  • 87.62

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.20
  • 12.12
  • 12.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.74
  • 34.84
  • 34.77

Earnings Forecasts:

(Updated: 30-05-2026)
Description
2024
2025
2026
2027
Adj EPS
132.66
167.55
210.73
263.61
P/E Ratio
61.64
48.80
38.80
31.02
Revenue
25138.3
29884.1
34401.4
40330
EBITDA
3722.05
4525.06
5500
6497.8
Net Income
1907.79
2401.84
3038.28
3735.41
ROA
8.98
10.56
12.11
13.68
P/B Ratio
12.00
10.11
8.15
6.22
ROE
20.77
22.13
22.71
22.78
FCFF
969.64
1841.7
2270.2
3711.45
FCFF Yield
0.76
1.44
1.78
2.91
Net Debt
3812.82
2533.93
1143.75
214.75
BVPS
681.36
808.5
1002.84
1315.49

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
6,605.50
5,592.20
18.12%
6,477.40
5,526.90
17.20%
6,303.50
5,589.30
12.78%
5,842.10
5,085.60
14.88%
Expenses
5,594.50
4,822.50
16.01%
5,512.10
4,765.40
15.67%
5,362.40
4,773.80
12.33%
4,990.20
4,410.50
13.14%
EBITDA
1,011.00
769.70
31.35%
965.30
761.50
26.76%
941.10
815.50
15.40%
851.90
675.10
26.19%
EBIDTM
15.31%
13.76%
14.90%
13.78%
14.93%
14.59%
14.58%
13.27%
Other Income
43.90
61.10
-28.15%
52.80
63.80
-17.24%
54.70
38.20
43.19%
40.20
37.20
8.06%
Interest
119.10
114.80
3.75%
112.60
109.80
2.55%
109.60
117.50
-6.72%
108.30
116.40
-6.96%
Depreciation
224.40
211.00
6.35%
219.20
184.60
18.74%
217.80
184.50
18.05%
214.70
177.40
21.03%
PBT
711.40
505.00
40.87%
667.10
530.90
25.65%
668.40
551.70
21.15%
569.10
418.50
35.99%
Tax
170.20
101.00
68.51%
165.70
156.80
5.68%
180.70
161.70
11.75%
141.70
114.50
23.76%
PAT
541.20
404.00
33.96%
501.40
374.10
34.03%
487.70
390.00
25.05%
427.40
304.00
40.59%
PATM
8.19%
7.22%
7.74%
6.77%
7.74%
6.98%
7.32%
5.98%
EPS
36.81
27.09
35.88%
34.93
25.89
34.92%
33.19
26.34
26.01%
30.10
21.23
41.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
25,228.50
21,794.00
19,059.20
16,612.50
14,662.60
10,560.00
11,246.80
9,617.40
8,243.47
7,255.70
6,214.65
Net Sales Growth
15.76%
14.35%
14.73%
13.30%
38.85%
-6.11%
16.94%
16.67%
13.61%
16.75%
 
Cost Of Goods Sold
13,075.60
11,310.00
9,805.50
8,574.30
7,573.50
5,684.20
5,498.90
4,660.90
4,032.66
3,598.88
3,054.74
Gross Profit
12,152.90
10,484.00
9,253.70
8,038.20
7,089.10
4,875.80
5,747.90
4,956.50
4,210.81
3,656.83
3,159.91
GP Margin
48.17%
48.10%
48.55%
48.39%
48.35%
46.17%
51.11%
51.54%
51.08%
50.40%
50.85%
Total Expenditure
21,459.20
18,772.20
16,668.50
14,562.90
12,477.50
9,426.90
9,665.80
8,554.70
7,452.09
6,548.95
5,534.38
Power & Fuel Cost
-
266.20
247.20
217.50
193.70
169.70
213.00
183.80
166.68
127.89
122.80
% Of Sales
-
1.22%
1.30%
1.31%
1.32%
1.61%
1.89%
1.91%
2.02%
1.76%
1.98%
Employee Cost
-
2,769.20
2,493.70
2,176.70
1,786.50
1,601.00
1,852.90
1,598.20
1,404.39
1,196.50
1,023.55
% Of Sales
-
12.71%
13.08%
13.10%
12.18%
15.16%
16.47%
16.62%
17.04%
16.49%
16.47%
Manufacturing Exp.
-
2,612.00
2,290.90
1,981.00
1,800.80
1,055.00
1,154.30
982.30
905.65
785.07
590.59
% Of Sales
-
11.98%
12.02%
11.92%
12.28%
9.99%
10.26%
10.21%
10.99%
10.82%
9.50%
General & Admin Exp.
-
1,634.50
1,707.10
1,494.40
1,009.10
691.40
716.30
988.70
817.35
744.85
663.71
% Of Sales
-
7.50%
8.96%
9.00%
6.88%
6.55%
6.37%
10.28%
9.92%
10.27%
10.68%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
180.30
124.10
119.00
113.90
225.60
230.40
140.80
125.35
95.77
0.00
% Of Sales
-
0.83%
0.65%
0.72%
0.78%
2.14%
2.05%
1.46%
1.52%
1.32%
1.27%
EBITDA
3,769.30
3,021.80
2,390.70
2,049.60
2,185.10
1,133.10
1,581.00
1,062.70
791.38
706.75
680.27
EBITDA Margin
14.94%
13.87%
12.54%
12.34%
14.90%
10.73%
14.06%
11.05%
9.60%
9.74%
10.95%
Other Income
191.60
200.30
106.30
90.30
78.20
49.10
33.20
32.40
33.95
44.33
52.54
Interest
449.60
458.50
449.40
380.80
378.60
449.20
532.80
327.00
295.07
257.35
180.02
Depreciation
876.10
757.50
687.00
615.40
600.70
573.10
619.70
395.50
359.03
314.04
263.83
PBT
2,616.00
2,006.10
1,360.60
1,143.70
1,284.00
159.90
461.70
372.60
171.24
179.69
288.95
Tax
658.30
534.00
445.50
256.20
477.00
84.70
225.10
173.40
111.91
90.96
96.90
Tax Rate
25.16%
26.62%
32.70%
22.40%
30.23%
38.38%
34.11%
46.54%
65.35%
50.62%
31.78%
PAT
1,957.70
1,445.90
898.60
862.30
1,048.30
149.60
458.00
235.00
117.42
220.99
236.38
PAT before Minority Interest
1,896.70
1,505.10
935.00
887.50
1,101.10
136.00
434.90
199.20
59.56
131.12
235.23
Minority Interest
-61.00
-59.20
-36.40
-25.20
-52.80
13.60
23.10
35.80
57.86
89.87
1.15
PAT Margin
7.76%
6.63%
4.71%
5.19%
7.15%
1.42%
4.07%
2.44%
1.42%
3.05%
3.80%
PAT Growth
32.99%
60.91%
4.21%
-17.74%
600.74%
-67.34%
94.89%
100.14%
-46.87%
-6.51%
 
EPS
136.14
100.55
62.49
59.97
72.90
10.40
31.85
16.34
8.17
15.37
16.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
8,212.30
6,935.40
6,197.40
5,623.30
4,602.50
3,339.10
3,333.50
3,251.51
3,313.20
3,331.13
Share Capital
71.90
71.90
71.90
71.90
71.90
69.60
69.60
69.56
73.01
69.56
Total Reserves
7,855.30
6,691.10
6,040.60
5,542.50
4,524.30
3,266.50
3,261.10
3,180.05
3,238.91
3,260.64
Non-Current Liabilities
7,778.30
5,033.90
6,225.50
6,242.00
5,590.10
6,482.70
4,613.00
4,423.17
4,398.65
2,700.91
Secured Loans
1,967.30
2,231.40
1,923.70
2,408.20
2,466.00
2,852.00
2,868.70
2,728.43
2,477.64
2,303.08
Unsecured Loans
2,449.70
4.20
13.90
19.00
7.40
0.00
83.40
195.37
475.74
146.70
Long Term Provisions
454.40
349.90
1,723.40
1,341.60
1,061.00
1,011.20
883.00
784.96
701.39
3.27
Current Liabilities
4,579.40
4,664.50
3,324.90
2,434.30
2,038.00
2,337.30
1,955.40
1,567.23
963.36
1,249.83
Trade Payables
2,240.50
2,368.60
1,915.60
1,631.80
1,160.00
908.80
713.10
606.02
501.19
550.19
Other Current Liabilities
1,567.30
1,425.90
684.80
472.10
382.40
807.80
640.80
501.70
295.59
446.16
Short Term Borrowings
590.20
725.30
609.10
208.50
385.90
497.50
498.20
379.17
70.69
182.93
Short Term Provisions
181.40
144.70
115.40
121.90
109.70
123.20
103.30
80.33
95.89
70.55
Total Liabilities
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
Net Block
10,985.40
9,660.50
8,515.70
8,290.90
6,773.00
7,426.20
4,975.10
4,765.71
4,583.29
3,997.42
Gross Block
16,180.60
14,193.30
12,473.20
11,717.50
9,612.40
10,222.00
6,599.50
6,023.63
5,499.02
4,609.14
Accumulated Depreciation
5,195.20
4,532.80
3,957.50
3,426.60
2,839.40
2,795.80
1,624.40
1,257.92
915.73
611.73
Non Current Assets
13,981.20
11,739.20
11,744.70
10,518.70
8,789.00
9,643.00
7,755.60
7,154.22
6,670.57
5,385.23
Capital Work in Progress
921.00
872.80
609.90
45.50
233.90
235.60
821.80
712.20
346.86
561.56
Non Current Investment
1,054.50
302.10
281.40
314.80
344.90
359.20
392.80
294.12
300.20
270.65
Long Term Loans & Adv.
944.20
833.90
2,178.80
1,769.30
1,421.30
1,598.40
1,431.60
1,254.62
1,325.53
498.28
Other Non Current Assets
73.30
66.50
154.80
93.50
10.60
17.70
127.80
120.43
106.93
57.33
Current Assets
7,029.40
5,279.70
4,337.00
4,060.60
3,641.50
2,646.80
2,281.80
2,220.13
2,129.22
1,974.57
Current Investments
1,432.30
684.00
292.20
501.30
997.80
74.90
68.80
57.87
105.84
81.73
Inventories
480.80
459.80
390.10
431.90
249.50
737.80
584.70
565.84
466.87
406.13
Sundry Debtors
3,016.10
2,514.90
2,234.20
1,764.70
1,331.10
1,027.20
1,023.20
825.19
750.53
609.37
Cash & Bank
1,360.20
933.80
775.80
924.00
724.40
466.80
346.90
417.25
524.50
378.79
Other Current Assets
740.00
258.20
226.40
141.00
338.70
340.10
258.20
353.97
281.47
498.55
Short Term Loans & Adv.
452.60
429.00
418.30
297.70
193.90
163.00
152.90
177.57
223.03
437.25
Net Current Assets
2,450.00
615.20
1,012.10
1,626.30
1,603.50
309.50
326.40
652.90
1,165.86
724.74
Total Assets
21,010.60
17,018.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
2,136.40
1,920.20
1,376.90
1,696.00
1,264.50
1,292.90
905.20
536.96
622.55
597.17
PBT
2,031.40
1,380.50
1,100.50
1,578.10
221.50
656.90
373.60
59.56
131.12
305.25
Adjustment
1,194.90
1,199.20
1,108.40
681.40
1,079.80
1,012.50
770.10
807.85
703.53
425.00
Changes in Working Capital
-603.90
-192.80
-450.00
-359.20
-72.10
-70.40
-46.00
-205.35
-78.48
10.82
Cash after chg. in Working capital
2,622.40
2,386.90
1,758.90
1,900.30
1,229.20
1,599.00
1,097.70
662.06
756.17
741.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-486.00
-466.70
-382.00
-204.30
35.30
-306.10
-192.50
-125.10
-133.62
-141.19
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.71
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3,380.60
-1,537.20
-870.60
-847.20
-863.40
-288.80
-710.60
-404.91
-1,151.88
-888.21
Net Fixed Assets
-830.60
-1,399.90
-324.10
-166.80
1,127.70
-2,378.60
-622.09
-796.57
-582.72
-278.38
Net Investments
-1,289.50
-404.00
-158.10
31.60
-1,014.40
9.00
-185.02
163.48
-186.58
-164.16
Others
-1,260.50
266.70
-388.40
-712.00
-976.70
2,080.80
96.51
228.18
-382.58
-445.67
Cash from Financing Activity
1,316.80
-311.10
-633.00
-791.60
-340.10
-909.60
-214.70
-108.50
476.95
329.93
Net Cash Inflow / Outflow
72.60
71.90
-126.70
57.20
61.00
94.50
-20.10
23.55
-52.37
38.89
Opening Cash & Equivalents
505.50
433.50
546.30
388.70
380.70
286.20
306.30
282.78
335.15
339.90
Closing Cash & Equivalent
578.10
505.50
433.40
546.50
425.20
380.70
286.20
306.33
282.78
378.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
550.72
469.76
424.53
389.89
319.08
239.10
238.71
233.02
237.25
238.81
ROA
7.92%
5.65%
5.79%
8.15%
1.10%
3.90%
2.05%
0.65%
1.10%
3.01%
ROE
20.51%
14.54%
15.16%
21.60%
3.44%
13.08%
6.07%
1.81%
2.68%
6.41%
ROCE
21.19%
19.27%
17.78%
24.92%
9.32%
17.13%
10.24%
7.12%
6.94%
8.57%
Fixed Asset Turnover
1.44
1.43
1.37
1.37
1.06
1.34
1.52
1.43
1.44
1.40
Receivable days
46.32
45.47
43.93
38.53
40.76
33.27
35.08
34.88
34.21
35.79
Inventory Days
7.88
8.14
9.03
8.48
17.06
21.46
21.83
22.86
21.96
22.21
Payable days
74.37
79.74
75.50
67.27
66.42
34.00
33.10
31.52
33.88
36.38
Cash Conversion Cycle
-20.18
-26.12
-22.54
-20.26
-8.60
20.73
23.81
26.22
22.28
21.62
Total Debt/Equity
0.67
0.47
0.44
0.47
0.62
1.08
1.10
1.06
0.95
0.85
Interest Cover
5.45
4.07
4.00
5.17
1.49
2.24
2.14
1.58
1.70
2.69

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Apollo Hospitals Enterprise reports 36% rise in Q4FY26 consolidated net profit
    21st May 2026, 11:27 AM

    Consolidated total income of the company increased by 17.62% at Rs 6,649.40 crore for Q4FY26

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    21st May 2026, 00:00 AM

    Read More
  • Apollo Hospitals Enterprise acquires additional stake in Apollo Health and Lifestyle
    11th Apr 2026, 13:02 PM

    Consequent to this acquisition, the company's shareholding in AHLL has now increased to 100%

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.